Page 5 - Oblte News Today

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 31,700 shares, an increase of 13.6% from the March 31st total of 27,900 shares. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares saw strong trading volume on Wednesday . 12,780 shares changed hands during mid-day trading, an increase of 27% from the previous session’s volume of 10,062 shares.The stock last traded at $29.75 and had previously closed at $29.87. Analysts Set New Price Targets A number of analysts have […]

Benchmark reissued their buy rating on shares of Belite Bio (NASDAQ:BLTE – Get Rating) in a research report report published on Tuesday, Benzinga reports. They currently have a $57.00 target price on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $58.00 target price on shares of Belite Bio in a report […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) gapped down before the market opened on Thursday . The stock had previously closed at $30.00, but opened at $28.85. Belite Bio shares last traded at $28.51, with a volume of 1,111 shares traded. Wall Street Analysts Forecast Growth A number of equities research analysts recently weighed in […]

Belite Bio (NASDAQ:BLTE – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $58.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 100.28% from the company’s previous close. Separately, […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares shot up 5.2% during trading on Tuesday . The stock traded as high as $30.00 and last traded at $30.00. 1,118 shares were traded during mid-day trading, a decline of 89% from the average session volume of 10,525 shares. The stock had previously closed at $28.51. Wall […]

Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Rating) dropped 4.6% during trading on Monday . The stock traded as low as $28.51 and last traded at $28.51. Approximately 1,999 shares traded hands during trading, a decline of 81% from the average daily volume of 10,531 shares. The stock had previously closed at $29.90. Analysts […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $28.20, but opened at $24.92. Belite Bio shares last traded at $22.23, with a volume of 805 shares trading hands. About Belite Bio (NASDAQ:BLTE) Belite Bio, Inc, a clinical-stage biopharmaceutical drug development […]

Belite Bio’s (NASDAQ:BLTE – Get Rating) quiet period is set to expire on Wednesday, June 8th. Belite Bio had issued 6,000,000 shares in its public offering on April 29th. The total size of the offering was $36,000,000 based on an initial share price of $6.00. During Belite Bio’s quiet period, underwriters and any insiders involved […]

Belite Bio, Inc. (BLTE) is planning to raise $36 million in an IPO on Friday, April 29th, IPO Scoop reports. The company will issue 6,000,000 shares at a price of $5.50-$6.50 per share. Belite Bio, Inc. has a market-cap of $144.6 million. The Benchmark Company acted as the underwriter for the IPO. Belite Bio, Inc. […]